Skip to content
Menu

UBS Maintains Neutral on Amrize, Raises Price Target to $46

Benzinga Newsdesk 2 hours ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

UBS analyst Julian Radlinger maintains Amrize (NYSE:AMRZ) with a Neutral and raises the price target from $42 to $46.

UBS analyst Julian Radlinger maintains Amrize (NYSE:AMRZ) with a Neutral and raises the price target from $42 to $46.

Read at benzinga.com